Join to View Full Profile
Ambulatory Clinic825 Eastlake Avenue EastSeattle, WA 98109
Phone+1 206-288-1000
Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2004
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1998 - 2001
University of Washington School of MedicineClass of 1998
Certifications & Licensure
MT State Medical License 2021 - 2027
WA State Medical License 2004 - 2027
MA State Medical License 2000 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone Start of enrollment: 2005 Dec 01
- Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer Start of enrollment: 2006 Dec 01
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- The Role of SPECT/CT in 177 Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression Patterns.Alireza Ghodsi, Ridvan Arda Demirci, Delphine L Chen, Peter S Nelson, Michael T Schweizer
Clinical Nuclear Medicine. 2025-08-01 - Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancer.Martine P Roudier, Roman Gulati, Erolcan Sayar, Radhika A Patel, Micah Tratt
The Journal of Clinical Investigation. 2025-06-10 - 2 citationsPembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Coh...Evan Y Yu, Cristiano Ferrario, Mark D Linch, Michael Stoeckle, Brigitte Laguerre
European Urology Oncology. 2025-06-01
Journal Articles
- Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing InterferenceMichael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology
- Undetectable Prostate‐Specific Antigen After Short‐Course Androgen Deprivation Therapy for Biochemically Recurrent Patients Correlates with Metastasis‐Free Survival an...Heather H Cheng, Jonathan T Wingate, Evan Y Yu, The Prostate
Lectures
- A randomized phase II study of atezolizumab plus recombinant human IL-7 (CYT107) or atezolizumab alone in patients with locally advanced or metastatic urothelial carci...2019 ASCO Annual Meeting - 6/1/2019
- Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC): Cohort A of the phase 1b/2 KEYN...2019 ASCO Annual Meeting - 6/1/2019
- Targeted Therapies in Advanced Urothelial Cancer2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Kineta Appoints Internationally-Renowned Clinical Immuno-Oncology Experts to Its Scientific Advisory BoardMarch 1st, 2023- What Is Phenotypic Precision Medicine and Its Role in GU Oncology? – Part 2May 18th, 2022
- What Is Phenotypic Precision Medicine and Its Role in GU Oncology? – Part 1May 18th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
